Page last updated: 2024-08-20

dextrothyroxine and Lymphoma

dextrothyroxine has been researched along with Lymphoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agnello, F; Albano, D; Cannizzaro, G; Ficola, U; Galia, M; Grassedonio, E; La Grutta, L; Lagalla, R; Midiri, M; Mulè, A; Patti, C1
Bentjen, SA; Mealey, KL; Northrup, NC1
Hillyer, MH; Love, S; Mair, TS1

Reviews

1 review(s) available for dextrothyroxine and Lymphoma

ArticleYear
Chronic diarrhoea in adult horses: a review of 51 referred cases.
    The Veterinary record, 1992, Mar-14, Volume: 130, Issue:11

    Topics: Animals; Chronic Disease; Codeine; Colitis; Diarrhea; Female; Horse Diseases; Horses; Ivermectin; Lymphoma; Male; Nematode Infections; Prednisolone; Retrospective Studies

1992

Other Studies

2 other study(ies) available for dextrothyroxine and Lymphoma

ArticleYear
Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
    European journal of radiology, 2016, Volume: 85, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Ivermectin; Lymphoma; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult

2016
Increased toxicity of P-glycoprotein-substrate chemotherapeutic agents in a dog with the MDR1 deletion mutation associated with ivermectin sensitivity.
    Journal of the American Veterinary Medical Association, 2003, Nov-15, Volume: 223, Issue:10

    Topics: Animals; Antinematodal Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dog Diseases; Dogs; Female; Gene Deletion; Genes, MDR; Ivermectin; Lymphoma; Pedigree; Treatment Outcome

2003